** Shares of medical device maker AFIB.O fall 6% to
$17.88, snapping a three-day rally
** Forecasts FY21 revenue of $22 mln to $30 mln, below
analysts' estimates of $43.5 mln, as COVID-19 headwinds are
likely to continue in 2021, particularly in H1
** Posts Q4 revenue of $2.6 mln, missing expectations of
$3.6 mln, as people delayed non-emergency surgeries due to the
pandemic
** However, CEO says that co is starting to see an
improvement in hospital access and number of procedures
urn:newsml:reuters.com:*:nGNX7m775F
** Stock down 38% YTD
(Reporting by Shreyasee Raj in Bengaluru)
((Shreyasee.Raj@thomsonreuters.com;))